Publications by authors named "Inmaculada Feria Vilar"

Background: Limited information is available on the active process of seeking medical help in patients with Alzheimer's disease (AD) at early stages. The aim of this study was to assess the phenomenon of medical help-seeking in early AD and to identify associated factors.

Methods: A multicenter, non-interventional study was conducted including patients of 50-90 years of age with prodromal or mild AD (National Institute on Aging/Alzheimer's Association criteria), a Mini-Mental State Examination (MMSE) score ≥ 22, and a Clinical Dementia Rating-Global score (CDR-GS) of 0.

View Article and Find Full Text PDF

Background: There is a need to better understand the experience of patients living with Alzheimer's disease (AD) in the early stages.

Objective: The aim of the study was to evaluate the perception of quality of life in patients with early-stage AD.

Methods: A multicenter, non-interventional study was conducted including patients of 50-90 years of age with prodromal or mild AD, a Mini-Mental State Examination (MMSE) score ≥22, and a Clinical Dementia Rating-Global score (CDR-GS) of 0.

View Article and Find Full Text PDF

Introduction: Limited information is available on people's experiences of living with Alzheimer's disease (AD) at earlier stages. This study assessed awareness of diagnosis among people with early-stage AD and its impact on different person-centered outcome measures.

Methods: We conducted an observational, cross-sectional study in 21 memory clinics in Spain.

View Article and Find Full Text PDF
Article Synopsis
  • Over half (57.4%) of hospitalized COVID-19 patients in a Spanish study experienced neurologic symptoms, with myalgias, headache, and dizziness being the most common early signs.
  • Anosmia and dysgeusia more frequently indicated early stages of the disease and were generally found in less severe cases, while disorders of consciousness were prevalent among older patients in severe conditions.
  • Neurologic complications contributed to 4.1% of patient deaths, highlighting the importance for clinicians to monitor and identify these symptoms promptly.
View Article and Find Full Text PDF